Literature DB >> 10082387

The defective interfering particles of equine herpesvirus 1 encode an ICP22/ICP27 hybrid protein that alters viral gene regulation.

M Chen1, K A Garko-Buczynski, Y Zhang, D J O'Callaghan.   

Abstract

The genomes of equine herpesvirus 1 (EHV-1) defective interfering (DI) particles that mediate persistent infection were shown to encode a unique hybrid open reading frame composed of sequences that encode the 196 N-terminal amino acids of ICP22 linked in-frame to the C-terminal 68 amino acids of ICP27. Previous studies demonstrated that this hybrid gene, designated as ICP22/ICP27. was expressed abundantly at both the mRNA and the protein levels in DI particle-enriched infections, but not in standard EHV-1 infection (Chen et al., 1996 J. Virol. 70, 313-320). Since the ICP22/ICP27 hybrid protein contains portions of two EHV-1 early regulatory proteins, its effect on EHV-1 gene regulation was investigated. In EHV-1-infected cells, the ICP22/ICP27 hybrid protein expressed from plasmid vectors significantly reduced expression of a reporter gene under the control of the EHV-1 immediate-early (IE) gene promoter and early gene promoter, such as the viral ICP27 gene. In uninfected cells, the ICP22/ICP27 hybrid protein moderately down-regulated the IE and ICP22 promoters, up-regulated late gene promoters such as IR5, and altered the regulatory function of the IE and 1CP22 proteins in co-transfected cells. These results demonstrated that DI particles might alter viral gene regulation by expression of a unique hybrid gene encoded on the DI particle genome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082387     DOI: 10.1016/s0168-1702(98)00128-2

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  9 in total

1.  Biological and genotypic properties of defective interfering particles of equine herpesvirus 1 that mediate persistent infection.

Authors:  Paul D Ebner; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2008-09-20       Impact factor: 3.616

2.  Genetic complexity of EHV-1 defective interfering particles and identification of novel IR4/UL5 hybrid proteins produced during persistent infection.

Authors:  Paul D Ebner; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2006-06       Impact factor: 2.332

3.  The EICP22 protein of equine herpesvirus 1 physically interacts with the immediate-early protein and with itself to form dimers and higher-order complexes.

Authors:  W A Derbigny; S K Kim; G B Caughman; D J O'Callaghan
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  The EHV-1 UL4 protein that tempers viral gene expression interacts with cellular transcription factors.

Authors:  Yunfei Zhang; Robert A Charvat; Seong K Kim; Dennis J O'Callaghan
Journal:  Virology       Date:  2013-11-21       Impact factor: 3.616

5.  Properties of an equine herpesvirus 1 mutant devoid of the internal inverted repeat sequence of the genomic short region.

Authors:  ByungChul Ahn; Yunfei Zhang; Nikolaus Osterrieder; Dennis J O'Callaghan
Journal:  Virology       Date:  2010-12-21       Impact factor: 3.616

6.  Deletion of the UL4 gene sequence of equine herpesvirus 1 precludes the generation of defective interfering particles.

Authors:  Robert A Charvat; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virus Genes       Date:  2012-07-03       Impact factor: 2.332

7.  The early UL3 gene of equine herpesvirus-1 encodes a tegument protein not essential for replication or virulence in the mouse.

Authors:  Byung Chul Ahn; Seongman Kim; Yunfei Zhang; Robert A Charvat; Dennis J O'Callaghan
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.513

8.  The IR4 auxiliary regulatory protein expands the in vitro host range of equine herpesvirus 1 and is essential for pathogenesis in the murine model.

Authors:  Jonathan E Breitenbach; Paul D Ebner; Dennis J O'Callaghan
Journal:  Virology       Date:  2008-11-13       Impact factor: 3.616

9.  The UL4 protein of equine herpesvirus 1 is not essential for replication or pathogenesis and inhibits gene expression controlled by viral and heterologous promoters.

Authors:  Robert A Charvat; Jonathan E Breitenbach; ByungChul Ahn; Yunfei Zhang; Dennis J O'Callaghan
Journal:  Virology       Date:  2011-02-15       Impact factor: 3.513

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.